cabozantinib and Pyoderma-Gangrenosum

cabozantinib has been researched along with Pyoderma-Gangrenosum* in 2 studies

2 other study(ies) available for cabozantinib and Pyoderma-Gangrenosum

Article	Year
A case of cabozantinib-induced pyoderma gangrenosum-like ulceration. The Australasian journal of dermatology, 2023, Volume: 64, Issue:1 Topics: Anilides; Humans; Pyoderma Gangrenosum; Pyridines	2023
Successful treatment of cabozantinib-induced pyoderma gangrenosum with ixekizumab therapy: A case report. Dermatologic therapy, 2022, Volume: 35, Issue:9 Topics: Anilides; Antibodies, Monoclonal, Humanized; Humans; Pyoderma Gangrenosum; Pyridines	2022